Skip to main content
SpringerLink
Log in

Rivaroxaban vs dabigatran etexilate in elderly patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Graham DJ, et al. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation. JAMA Internal Medicine : 3 Oct 2016. Available from: URL: http://dx.doi.org/.1001/jamainternmed.2016.5954

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivaroxaban vs dabigatran etexilate in elderly patients. Reactions Weekly 1624, 10 (2016). https://doi.org/10.1007/s40278-016-22216-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-22216-x

Search

Navigation